Key facts
| Recalling firm | Philips Ultrasound, LLC |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | Philips EPIQ Elite Diagnostic Ultrasound System Model # 795234 |
| Classification | Class II |
| Recall number | Z-3249-2026 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | Due to software issue with ultrasound system, doppler sample is displayed shallower than its actual measurement location, potentially causing inaccurate blood flow velocity measurements and misdiagnosis. |
What this classification means
A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.
What consumers should do
Facilities, clinicians, and consumers holding an affected unit or lot of Philips EPIQ Elite Diagnostic Ultrasound System Model # 795234 should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Philips Ultrasound, LLC. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Philips Ultrasound, LLC should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Philips Ultrasound, LLC directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.
Frequently asked questions
- Where can I verify this recall directly with FDA?
- The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.
- Is Philips EPIQ Elite Diagnostic Ultrasound System Model # 795 recalled?
- Yes. FDA lists a Class II recall by Philips Ultrasound, LLC for Philips EPIQ Elite Diagnostic Ultrasound System Model # 795234, reported 20260930, with status "Ongoing." FDA recall number: Z-3249-2026.
- What is the recall class for Philips Ultrasound, LLC's recall?
- FDA classified this recall as Class II. A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
- Why was Philips EPIQ Elite Diagnostic Ultrasound System Model # 795 recalled?
- FDA's recall record states the reason as: Due to software issue with ultrasound system, doppler sample is displayed shallower than its actual measurement location, potentially causing inaccurate blood flow velocity measurements and misdiagnosis.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for Philips Ultrasound, LLCCompiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). Recall Record: Class II Recall: Philips EPIQ Elite Diagnostic Ultrasound System Model #… by Philips Ultrasound, LLC. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/recall/philips-ultrasound-z-3249-2026-2026-09-30
"Recall Record: Class II Recall: Philips EPIQ Elite Diagnostic Ultrasound System Model #… by Philips Ultrasound, LLC." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/recall/philips-ultrasound-z-3249-2026-2026-09-30.
Argus HQ Research. "Recall Record: Class II Recall: Philips EPIQ Elite Diagnostic Ultrasound System Model #… by Philips Ultrasound, LLC." Digital Empire Holdings LLC. Accessed October 12, 2026. https://argushq.ai/recall/philips-ultrasound-z-3249-2026-2026-09-30.
@misc{argushq_argushq_ai_recall_philips_ultrasound_z_3249_2026_2026_09_30_2026,
title = {Recall Record: Class II Recall: Philips EPIQ Elite Diagnostic Ultrasound System Model #… by Philips Ultrasound, LLC},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/recall/philips-ultrasound-z-3249-2026-2026-09-30},
note = {Accessed: October 12, 2026}
}Source: FDA.gov — Recalls ↗

